Assignment of Assignor's Interest

Recorded: 2018-04-23 Pages: 3

Assignor

XIONG, XIAOFENG

Executed: 2017-11-07

Assignee

EIGER BIOPHARMACEUTICALS, INC.

350 CAMBRIDGE AVENUE, SUITE 350, PALO ALTO, CALIFORNIA, 94306

Covered Property (1)

Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives

PCT: PCT/US2017/020596 ↗

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.